Published on October 30, 2026
Inflammatory Memory in the Gut: How Past Injury Teaches the Intestine to Repair Faster
🇮🇹 Leggi in Italiano
The intestinal epithelium renews itself every few days, and when injury kills the stem cells that sustain this turnover, repair proceeds along two routes: proliferation of the stem cells that survive, and cellular plasticity, whereby already differentiated cells revert to a stem-like state. Whether the inflammation accompanying such repair leaves a durable trace has long remained unclear, and previous work in colitis models portrayed such memory mainly as a maladaptive legacy priming tissue for later tumor growth. A study published on October 27, 2026, in Nature Communications by Borja Arozamena and colleagues at IDIBELL in Barcelona now documents the opposite face of the same phenomenon.
The investigators irradiated the abdomen of mice at 14 Gy and delivered a second dose 21 days later, using heritable labels to follow stem cells (Lgr5) separately from already differentiated cells (Krt20), so that survivors could be told apart from reverted cells. Three weeks after the first insult they profiled, cell by cell, both gene activity and the state of the chromatin — which stretches of DNA remain unwound and available to be read — and found a persistent transcriptional and epigenetic imprint: thousands of genes remained abnormally expressed — 1,372 in the surviving stem cells and 2,939 in those arising from reversion — while the DNA around immune genes such as Cd74 and Ciita stayed open, exposing docking sites for inflammatory transcription factors including AP-1, STAT1, and IRF1, though mostly without a matching rise in transcription, chromatin left poised rather than active.
Functionally, recovery after the second irradiation proved faster, with body weight rebounding about a day earlier and the proliferation markers Ki67 and EdU higher at day five, whereas cleaved caspase-3 — a marker of cell death — was comparable across both rounds, importantly indicating that initial damage was similar and the advantage lay in repair, not in protection from injury. Interferon-γ emerged as the critical driver of this primed state: a brief exposure gave organoids, the miniature intestines grown in culture, a partial survival advantage, and blocking the cytokine during the first injury blunted the accelerated recovery while restoring toward normal some 6,389 DNA regions that had lost accessibility.
Unfortunately, the limitations are substantial: the model is murine, the control design cannot separate baseline effects of interferon-γ blockade from injury-specific ones, the cellular source of the cytokine was not identified, and organoid priming only partly reproduces the in vivo response. The therapeutic logic is nonetheless appealing, since a controlled inflammatory signal might precondition the epithelium before radiotherapy or transplantation, although the reliance on AP-1 counsels caution, that factor having been linked to memory favoring tumorigenesis. Whether inflammation without injury suffices to write such a record, and whether it behaves comparably in human tissue, each stand as an invitation to further research, where tissue resilience and disease susceptibility prove to be two readings of one molecular registry.
Source: Arozamena B, Moraitis I, Mularoni L, et al. Inflammatory memory primes the intestine for enhanced regenerative potential. Nature Communications 2026;17. DOI: 10.1038/s41467-026-79014-6 | PMID: 42946733 (open access)
Topics